A detailed history of Stonnington Group, LLC transactions in Danaher Corp stock. As of the latest transaction made, Stonnington Group, LLC holds 13,511 shares of DHR stock, worth $3.18 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares
13,511
Previous 13,911 2.88%
Holding current value
$3.18 Million
Previous $3.69 Million 7.77%
% of portfolio
0.89%
Previous 1.04%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 14, 2023

SELL
$239.75 - $277.0 $95,900 - $110,800
-400 Reduced 2.88%
13,511 $3.41 Million
Q4 2022

Jan 11, 2023

SELL
$241.42 - $282.29 $1.02 Million - $1.2 Million
-4,240 Reduced 23.36%
13,911 $0
Q3 2022

Oct 20, 2022

BUY
$247.06 - $1507.4 $375,531 - $2.29 Million
1,520 Added 9.14%
18,151 $4.68 Million
Q2 2022

Jul 08, 2022

BUY
$237.11 - $299.66 $353,293 - $446,493
1,490 Added 9.84%
16,631 $4.38 Million
Q1 2022

Apr 12, 2022

SELL
$257.27 - $315.76 $24.3 Million - $29.9 Million
-94,584 Reduced 86.2%
15,141 $4.41 Million
Q4 2021

Jan 12, 2022

BUY
$292.08 - $329.01 $27.5 Million - $30.9 Million
94,050 Added 600.0%
109,725 $33.5 Million
Q4 2021

Jan 12, 2022

SELL
$292.08 - $329.01 $998,913 - $1.13 Million
-3,420 Reduced 17.91%
15,675 $4.79 Million
Q3 2021

Oct 12, 2021

BUY
$272.21 - $332.43 $550,136 - $671,841
2,021 Added 11.84%
19,095 $5.72 Million
Q2 2021

Jul 09, 2021

BUY
$225.08 - $271.69 $45,016 - $54,338
200 Added 1.19%
17,074 $4.73 Million
Q1 2021

May 21, 2021

BUY
$212.38 - $245.9 $3.58 Million - $4.15 Million
16,874 New
16,874 $4.22 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $171B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Stonnington Group, LLC Portfolio

Follow Stonnington Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonnington Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonnington Group, LLC with notifications on news.